Don't Just Read the News, Understand It.
Published loading...Updated

Pharmalittle: We're Reading About FDA and Gene Therapies, a Kidney Disease Showdown, and More

Summary by STAT
Sanofi is speeding shipments of its RSV antibody Beyfortus to get ahead of what it believes will be strong demand in the 2025–2026 season

3 Articles

All
Left
1
Center
1
Right

A two-year survey reveals major flaws in the FDA's drug approval system. Journalists, Jeanne Lenzer and Shannon Brownlee, expose hundreds of licensed drugs without evidence of efficacy. In addition, some treatments even show signs of ineffectiveness or danger. Thus, patients become "involuntary guinea pigs" for questionable therapies. First, the FDA often uses weak approval criteria, such as observational studies. These studies, less rigorous th…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Le Libre Penseur broke the news in on Saturday, June 7, 2025.
Sources are mostly out of (0)